Adaptor protein-2 (AP2), a central component of clathrincoated vesicles (CCVs), is pivotal in clathrin-mediated endocytosis, which internalizes plasma membrane constituents such as G protein-coupled receptors (GPCRs) 1-3 . AP2, a heterotetramer of a, b, m and s subunits, links clathrin to vesicle membranes and binds to tyrosine- and dileucine-based motifs of membrane-associated cargo proteins 1,4 . Here we show that missense mutations of AP2 s subunit (AP2S1) affecting Arg15, which forms key contacts with dileucine-based motifs of CCV cargo proteins 4 , result in familial hypocalciuric hypercalcemia type 3 (FHH3), an extracellular calcium homeostasis disorder affecting the parathyroids, kidneys and bone 5-7 . We found AP2S1 mutations in >20% of cases of FHH without mutations in calcium-sensing GPCR (CASR) 8-12 , which cause FHH1. AP2S1 mutations decreased the sensitivity of CaSR-expressing cells to extracellular calcium and reduced CaSR endocytosis, probably through loss of interaction with a C-terminal CaSR dileucine-based motif, whose disruption also decreased intracellular signaling. Thus, our results identify a new role for AP2 in extracellular calcium homeostasis.
We initially identified AP2S1 mutations by exome capture and high-throughput sequence analysis of genomic DNA from an affected individual from each of two unrelated kindreds with FHH3 (FHH3 OK and FHH3 NI ; Table 1 and Supplementary Fig. 1 ) [5] [6] [7] . This analysis identified over 2,500 previously unreported nonsynonymous singlenucleotide variants (SNVs) in the whole exome of each subject. An analysis of SNVs within the 3.46-Mb interval at 19q13.3, which is the location of the FHH3 locus 6, 7 and contains ~110 genes, identified one SNV, a C>T transition in exon 2 of AP2S1, which encodes the AP2σ2 protein 13 , in affected individuals from both kindreds. We confirmed the C>T transition, which predicted the occurrence of a missense alteration (p.Arg15Cys), by dideoxynucleotide sequencing ( Supplementary Fig. 1 ) and used the resulting alterations in restriction endonuclease (HhaI and BmgBI) sites to demonstrate its co-segregation with FHH3 in members (32 affected and 23 unaffected) from four generations of the two kindreds ( Supplementary Fig. 1 ).
FHH3, together with FHH1 and FHH2, are genetically heterogeneous autosomal dominant disorders of extracellular calcium (Ca o 2+ ) homeostasis that are characterized by lifelong elevations of serum calcium concentrations with inappropriately low urinary calcium excretion (mean urinary calcium to creatinine clearance ratio <0.01) 5, 9, 11 . The loci for FHH1, FHH2 and FHH3 are located at chromosomes 3q21. 1, 19p and 19q13 .3, respectively [6] [7] [8] 14 . FHH1 and FHH2 are usually associated with normal circulating parathyroid hormone (PTH) concentrations and mild hypermagnesemia and are generally asymptomatic disorders 9, 11 , although some individuals with FHH1 may suffer from pancreatitis, chondrocalcinosis or primary hyperparathyroidism caused by excessive PTH secretion by parathyroid tumors, which in neonates may result in life-threatening hypercalcemia, hypotonia, bone demineralization, fractures and respiratory distress and in adults may be associated with osteoporosis and kidney stones 9, 11 . FHH3 is characterized by different clinical features, which include increased serum PTH concentrations, hypophosphatemia and osteomalacia 5, 7 . Approximately 65% of individuals with FHH have FHH1 caused by loss-of-function mutations in CASR, which encodes a GPCR [8] [9] [10] [11] . To determine the frequency of AP2S1 mutations in the remaining ~35% of individuals with FHH, we performed DNA sequence analysis of the five exons and eight intron-exon boundaries of AP2S1 in 50 unrelated individuals with FHH in whom CASR mutations had been excluded 9 . This analysis identified 11 missense heterozygous mutations, consistent with autosomal dominant inheritance, all of which affected Arg15 and consisted of four p.Arg15Cys, three p.Arg15His and four p.Arg15Leu alterations ( Table 1 and Supplementary Fig. 1 ). Individuals with these AP2S1 mutations, whose ages ranged from 8 days to 78 years (Table 1) , had similar elevations in serum calcium and PTH concentrations and reductions in urine calcium excretion, thereby indicating an absence of correlation between the mutation and clinical phenotype. However, the occurrence of these three different AP2S1 mutations that altered only the Arg15 residue in 13 unrelated Mutations in AP2S1 cause familial hypocalciuric hypercalcemia type 3 l e t t e r s probands, and the significant conservation of this codon in 5,400 human exomes (P < 10 −10 by Fisher exact test), indicates that this residue represents a probable mutational hotspot in FHH3. Indeed, AP2S1 missense mutations affecting Arg15 may be the underlying cause of FHH in >20% of individuals without CASR mutations.
The observation of 13 FHH3-associated AP2S1 mutations that involved solely the Arg15 residue (Table 1) , which is evolutionarily conserved in all AP2σ2 subunit orthologs and human adaptor protein σ subunit paralogs (Fig. 1a) 3 , indicated that this residue probably has a crucial role in the AP2 complex. Indeed, an analysis of the crystal structure of AP2 showed that the Arg15 residue of AP2σ2 and the Arg21 residue of AP2α1 are involved in forming key contacts with a glutamine residue at position −4 relative to the first leucine of the dileucine motif of cargo proteins (Fig. 1b) 4 . Replacing the positively charged Arg15 residue with either the polar but uncharged Cys15 residue (Fig. 1c) or the nonpolar Leu15 residue (Fig. 1d) is predicted to lead to a reduced affinity for the dileucine motif and, hence, compromise adaptor function. However, the effects of the His15 substitution (Fig. 1e) are more difficult to predict, as arginine and histidine are both positively charged residues. We hypothesized that these predicted effects of the FHH3-associated AP2S1 mutants may decrease the sensitivity of cells expressing CaSR to Ca o 2+ and reduce CaSR endocytosis for four reasons. First, AP2 is known to have an important role in GPCR endocytosis and recycling, thereby influencing GPCR sensitivity (Fig. 2) 15 . Second, CaSR has within its cytoplasmic C-terminal domain a variant dileucine motif (RHQPLL, residues 1009-1014) 9, 16 . Third, CaSR is pivotal in Ca o 2+ homeostasis (Fig. 2) and mediating changes in PTH secretion and renal tubular calcium reabsorption in response to alterations in plasma calcium concentrations [9] [10] [11] [12] . Fourth, CASR loss-of-function mutations in individuals with FHH1 cause a decrease in the sensitivity of cells expressing CaSR [8] [9] [10] 12, 17 . npg l e t t e r s Fig. 2) . Expression of the mutant CaSR led to a rightward shift in the concentration-response curves, with a significantly higher EC 50 value (the [Ca 2+ ] o required to produce a half-maximal increase in [Ca 2+ ] i ) (mutant EC 50 = 3.63 mM, 95% CI 3.57-3.68 mM (n = 8) compared to wild-type EC 50 = 3.41 mM, 95% CI 3.36-3.46 mM (n = 8); P < 0.0001) (Supplementary Fig. 3) . Figure 2 Schematic model for CaSR signaling and its endocytosis mediated by β-arrestin and AP2. Ligand binding of calcium ions (yellow) by GPCR CaSR (gray) results in G protein-dependent stimulation, through G q/11 , of phospholipase C β (PLC-β, orange) activity, causing an accumulation of inositol 1,4,5-trisphosphate (IP 3 ) and rapid release of calcium ions from intracellular stores (Ca i 2+ ), as well as an increase in diacylglycerol (DAG) concentrations and stimulation of protein kinase C (PKC), which phosphorylates CaSR threonine residues (red P) that in turn promotes binding by β-arrestin (brown) and initiates CaSR internalization 10, 15, 17, 28 . AP2 (purple) has a pivotal role in initiating GPCR internalization by binding the β-arrestin tyrosine motif (YxxΦ) through its µ2 subunit; alterations of the AP2 µ2 subunit disrupt binding to the β-arrestin tyrosine motif and severely impair clathrinmediated endocytosis 29 . AP2, which is a central component of CCVs, links clathrin to the vesicle membrane and binds to the tyrosine-and dileucine-based motifs of membrane-associated 
npg l e t t e r s
Thus, these results indicate that the CaSR dileucine motif is functionally important. Second, we established HEK293 cells that stably expressed CaSR and transiently transfected them with either wildtype or mutant AP2S1-pBI-CMV2 expression constructs. We specifically chose to subclone the full-length coding region of AP2S1 into the bidirectional vector pBI-CMV2, which contains a GFP reporter gene (Fig. 3a) , as it allowed coexpression of AP2σ2 and GFP at equivalent levels ( Fig. 3b) without the requirement of tagging the small (17 kDa) AP2σ2 protein that may have altered its function 23 . After transient transfection with either the wild-type or mutant AP2S1-pBI-CMV2 constructs, we detected the expression of CaSR, AP2σ2 and GFP, which also represented a surrogate marker for transfected AP2σ2, by immunofluorescence, western blot analysis or both (Fig. 3a,b) . This analysis showed that expression of all three mutant AP2σ2 proteins led to a rightward shift in the concentration-response curves (Fig. 3c-e Table 2 ). The increase in the CaSR EC 50 value induced by the FHH3-associated AP2S1 mutants indicates a decrease in the sensitivity of cells expressing CaSR to extracellular calcium, and this is consistent with the effects of the loss-of-function CASR mutations reported in FHH1 (refs. 9,12). Moreover, the EC 50 values of the cells transfected with the Leu15 and His15 AP2S1 mutants were similar to those of cells transfected with vector alone, whereas the EC 50 values of cells transfected with the Cys15 AP2S1 mutant were significantly higher than those of cells transfected with vector alone, indicating a possible dominant-negative effect for this AP2S1 mutant ( Table 2) .
To investigate the effect of the AP2S1 Arg15 alterations on CaSR endocytosis, we evaluated CaSR cell-surface expression by an intact cell ELISA 18 under basal and stimulated conditions using 0.5 mM and 5 mM Ca o 2+ , respectively, in HEK293 cells that were stably transfected with CaSR ( Table 3 ). The basal cell-surface expression of CaSR in cells transfected with wild-type or mutant AP2S1 or vector alone was similar ( (Table 3) . However, after stimulation with increased [Ca 2+ ] o , cells transfected with wild-type AP2S1 had a significant further reduction of cell-surface CaSR expression when compared to cells transfected with mutant p.Arg15Cys AP2S1 or vector alone, whereas those cells transfected with mutant p.Arg15Cys AP2S1 had a similar CaSR cell-surface expression to that of cells transfected with vector alone (Table 3) . These results indicate that the effect of the transfected wild-type AP2S1 is to raise the total amount of available wild-type AP2σ2 (that is, endogenous plus transfected AP2σ2), which increases CaSR endocytosis; however, this increased CaSR endocytosis is not found in cells transfected with the AP2S1 mutant, which instead is associated with decreased CaSR internalization ( Table 3) . Thus, our studies demonstrate that AP2σ2 has a role in CaSR endocytosis as well as in the regulation of CaSR signaling through Ca i 2+ (Fig. 2) , a pathway pivotal for Ca o 2+ homeostasis, such that its disruption by AP2S1 Arg15 alterations results in FHH3.
Our study, which represents, to our knowledge, the first report of a disease-causing mutation in an AP2 subunit gene, demonstrates that missense alterations (p.Arg15Cys, p.Arg15His and p.Arg15Leu) (Supplementary Fig. 1 ) of AP2σ2, a ubiquitously expressed protein (Supplementary Fig. 2 ) that forms part of the AP2 heterotetrameric complex 1 , do not result in a multisystem disorder but instead result in a specific disorder of extracellular calcium homeostasis involving the parathyroids, kidneys and bone [5] [6] [7] . A possible explanation could be that alteration of Arg15, which was found to be the only residue involved in an analysis of >50 unrelated individuals with FHH, probably has a specific effect, such as recognition of the CaSR dileucine motif by AP2σ2. This implies that mutations of other AP2S1 codons may result in different diseases, and the situation may be analogous to that reported for different alterations of LMNA (encoding lamin A), which are associated with six different tissue-specific diseases 27 . Thus, our results, which show that mutations affecting a specific residue (Arg15) of AP2σ2 cause FHH3, demonstrate a previously unrecognized role for AP2σ2 in extracellular calcium homeostasis.
URLs. Stampy, http://www.well.ox.ac.uk/project-stampy; Platypus, http://www.well.ox.ac.uk/platypus; PolyPhen-2, http://genetics. bwh.harvard.edu/pph2/; SIFT, http://sift.jcvi.org/; MutationTaster, http://www.mutationtaster.org/; Exome Variant Server, NHLBI Exome Sequencing Project (ESP), Seattle, Washington, USA, http:// evs.gs.washington.edu/EVS/.
MeTHodS
Methods and any associated references are available in the online version of the paper.
Accession code. The AP2S1 reference sequence is available at GenBank under accession NM_004069.3. 18 . Results were normalized to vectoronly-transfected cells, as previously reported 18 , and are shown as the mean ± s.e.m. (n = 6) for each experiment. Comparison of total CaSR expression at 0.5 mM and 5 mM showed no significant difference. Comparison of cell-surface CaSR expression showed significant differences as follows: a compared to vector (0.5 mM) at P < 0.005; b compared to wild-type (0.5 mM) at P < 0.005; c compared to mutant (5 mM) at P < 0.05; d compared to vector (5 mM) at P < 0.005; e compared to mutant (0.5 mM) at P < 0.005. npg l e t t e r s 7 . In addition, we investigated 50 reported individuals with FHH 9 (23 males and 27 females) in whom CASR mutations had not been detected. Clinical details of the two FHH3 kindreds [5] [6] [7] and the subjects with FHH without CASR mutations have been reported previously 9 (Supplementary Note).
Note: Supplementary information is available in the online version of the paper.
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Exome capture and DNA sequencing. Leukocyte DNA was prepared from venous blood 6, 9 , quantified using the High Sensitivity Qubit system (Invitrogen) and assessed for integrity using an agarose gel. Three micrograms of DNA were fragmented, and libraries were prepared using the SureSelect Human All Exon v2 Kit (Agilent Technologies) as follows 31 . Fragmented DNA was amplified using universal adaptor sequences, and the amplified library was hybridized to the SureSelect oligonucleotides before additional rounds of amplification. Libraries were quality checked using the 2100 Bioanalyzer (Agilent Technologies) and quantified by quantitative RT-PCR (qRT-PCR) before analysis by an Illumina GAIIx using 50-bp paired-end reads 31, 32 .
Bioinformatic analysis of exome sequence data. Data were aligned to the Human37 reference genome build using an in-house short-read mapper (Stampy) 33 and stored in BAM format 34 . Sufficient target-region coverage (greater than ten base reads) was verified in excess of 70% for the analyzed samples. Identification of variant sites and alleles was performed with an in-house variant caller (Platypus), which can detect SNVs and short (<50 bp) insertions/deletions (indels). Variants were reported in a final output VCF file and filtered to reduce the false-positive rate. Variants previously reported in the dbSNP v.135 or 1000 Genomes databases were excluded from further analysis. Remaining variants were examined using the programs PolyPhen-2, SIFT and MutationTaster to predict the effect on the encoded protein and on conservation and expression. Aligned reads were viewed with the Integrative Genomics Viewer 35 .
Sanger (dideoxynucleotide chain termination) sequencing of AP2S1. Leukocyte DNA was used with AP2S1-specific primers (Supplementary Table 1 ) for PCR amplification of the five exons and eight intron-exon boundaries, and the DNA sequences of the PCR products were determined using the BigDye Terminator v3.1 Cycle Sequencing Kit (Life Technologies) and an ABI 3730 automated capillary sequencer (Applied Biosystems) 9 . DNA sequence abnormalities and co-segregation in families were confirmed by restriction endonuclease analysis (New England Biolabs), as previously described 24 . In addition, the DNA sequence abnormalities were confirmed by high-resolution melting (HRM) curve analysis using a Rotor-Gene Q (Qiagen) 36 . Sequence changes were compared with data from the National Heart, Lung, and Blood Institute Exome Sequencing Project (NHLBI-ESP), which provides the exome sequences from ~5,400 samples, to assess whether they represent rare polymorphisms that may occur in 0.1% of the population.
Protein sequence analysis and computer modeling of the AP2 structure. Protein sequences of AP2σ2 orthologs and paralogs were aligned with Clustal W 37 . The crystal structure of the AP2 heterotetramer bound to an acidic dileucine peptide has been reported previously 4 . The PyMOL Molecular Graphics System (version 1.2r3pre, Schrödinger) was used to model the effect of the FHH3-associated AP2S1 mutations on interaction with the acidic dileucine motif peptide using the three-dimensional structure of AP2 archived in the Protein Data Bank at the European Bioinformatics Institute with the accession number 2JKR 4, 25 .
Functional expression of CASR and AP2S1 mutations. Functional studies to assess CaSR signaling were performed in HEK293 cells because suitable parathyroid and renal tubular cells are not available, and HEK293 cells have been established as a model for such studies 9, 12, 18, 19, 21, 22 . The previously reported cells or HEK293 cells stably transfected with CaSR were used 24 . First-strand cDNA was produced from 1 µg of total RNA using the Quantitect Reverse Transcription Kit (Qiagen) 24 . To investigate alternative splicing, RT-PCR was performed using AP2S1-specific primers (Supplementary To quantify AP2S1 expression, real-time qRT-PCR was performed with Quantitect gene expression assays (Qiagen) using the Rotorgene-Q system. Ct values were collected for AP2S1 and the housekeeping genes GAPDH, PGK and B2M during the log phase of the cycle. AP2S1 values were normalized to the geometric mean of the three housekeeping genes for each sample and expressed as an arbitrary percentage of the housekeeper expression geometric mean.
Statistical analyses. The prevalence of AP2S1 variants was compared to the corresponding prevalence in a large set of control exomes with a Fisher's exact test 32 . For the in vitro functional expression studies, the mean EC 50 value from a minimum of 12 separate transfection experiments was used for statistical comparison using the F test 19 .
